hCAIX-IN-22 is a highly selective inhibitor of the human carbonic anhydrase (hCA) XII subtype, exhibiting anticancer activity with an inhibition constant (Ki) of 9.7 nM.
Target:
Carbonic Anhydrase
* VAT and and shipping costs not included. Errors and price changes excepted